Raymond E. Counsell
Impact in
- Clinical Biochemistry top 1%
- Paraoxonase enzyme and polymorphisms
- Biochemistry top 2%
Papers in
- Biochemistry 27
- Eicosanoids and Hypertension Pharmacology 18
-
- Chemical Reactions and Isotopes 17
- Co-authors
- Robert H. SeeversJamey P. WeichertMarc A. LonginoWilliam H. BeierwaltesCary HsuRobert W. BrueggemeierDragomir DraganovP. Stetson
- Journals
- Journal of Medicinal Chemistry (51 papers)Journal of Pharmaceutical Sciences (14 papers)Steroids (10 papers)Academic Radiology (5 papers)Journal of Pharmacology and Experimental Therapeutics (5 papers)
- Partner nations
- United StatesAustraliaSweden
In The Last Decade
Raymond E. Counsell
158 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 108
- Clinical Biochemistry 281
- Biochemistry 226
- Cancer Research 381
- Radiology, Nuclear Medicine and Imaging 517
- Pharmaceutical Science 127
Countries citing papers authored by Raymond E. Counsell
This map shows the geographic impact of Raymond E. Counsell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond E. Counsell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond E. Counsell more than expected).
Fields of papers citing papers by Raymond E. Counsell
This network shows the impact of papers produced by Raymond E. Counsell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond E. Counsell. The network helps show where Raymond E. Counsell may publish in the future.
Co-authors
The 25 scholars most cited alongside Raymond E. Counsell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2002 | 4 | |
| 3 | 2001 | 18 | |
| 4 | 2000 | 23 | |
| 5 | 1998 | 38 | |
| 6 | 1997 | 21 | |
| 7 | 1996 | 7 | |
| 8 | 1996 | 8 | |
| 9 | 1996 | 16 | |
| 10 | 1995 | 29 | |
| 11 | 1995 | 47 | |
| 12 | 1995 | 1 | |
| 13 | 1995 | 42 | |
| 14 | 1995 | 5 | |
| 15 | 1995 | 11 | |
| 16 | 1992 | 5 | |
| 17 | 1989 | 4 | |
| 18 | 1987 | 2 | |
| 19 | 1986 | 4 | |
| 20 | 1968 | 30 |
About Raymond E. Counsell
Raymond E. Counsell is a scholar working on Biochemistry, Pharmaceutical Science, Radiology, Nuclear Medicine and Imaging, Cancer Research and Hepatology, having authored 163 papers that have together received 2.4k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (40 papers), Cancer, Hypoxia, and Metabolism (28 papers), Medical Imaging Techniques and Applications (27 papers), Estrogen and related hormone effects (26 papers), Steroid Chemistry and Biochemistry (18 papers), Eicosanoids and Hypertension Pharmacology (18 papers), Chemical Reactions and Isotopes (17 papers) and Inflammatory mediators and NSAID effects (13 papers). The work is most often cited by research in Clinical Biochemistry (281 citations), Biochemistry (226 citations), Cancer Research (381 citations), Radiology, Nuclear Medicine and Imaging (517 citations) and Pharmaceutical Science (127 citations). Raymond E. Counsell has collaborated with scholars based in United States, Australia and Sweden. Frequent co-authors include Robert H. Seevers, Jamey P. Weichert, Marc A. Longino, William H. Beierwaltes, Cary Hsu, Robert W. Brueggemeier, Dragomir Draganov, P. Stetson, Bert N. La Du and Scott S. Billecke. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmaceutical Sciences, Steroids, Academic Radiology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.